Seeing Is Believing
Healthcare - Sector
La Jolla Pharmaceutical Co's activity chart (see below) currently has 46 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 21.85% with an average time for these price targets to be met of 52.33 days.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 25-Jan-2021. First documented stock forecast 06-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
$15
$8.78 (141.16%)
$20
5 years 6 months 7 days ago
(25-Jan-2021)
0/2 (0%)
$9.34 (165.02%)
Hold Since 26-Nov-2019
$19
6 years 8 months 6 days ago
(26-Nov-2019)
0/9 (0%)
$12.7 (201.59%)
Buy Since 07-Jun-2019
$3
$-3.22 (-51.77%)
$20
6 years 8 months 7 days ago
(25-Nov-2019)
1/2 (50%)
$0.41 (15.83%)
9
Buy Since 09-Feb-2016
$25
$18.78 (301.93%)
$50
7 years 2 months 25 days ago
(07-May-2019)
0/5 (0%)
$17.31 (225.10%)
Sell Since 26-Jan-2018
$18
$11.78 (189.39%)
$21
7 years 6 months 9 days ago
(23-Jan-2019)
4/5 (80%)
$12.01 (200.50%)
144
What is LJPC (La Jolla Pharmaceutical Co) average time for price targets to be met?
Which analyst has the current highest performing score on LJPC (La Jolla Pharmaceutical Co) with a proven track record?
Which analyst has the most public recommendations on LJPC (La Jolla Pharmaceutical Co)?
Which analyst is the currently most bullish on LJPC (La Jolla Pharmaceutical Co)?
Which analyst is the currently most reserved on LJPC (La Jolla Pharmaceutical Co)?